AKT as a Therapeutic Target for Cancer
Top Cited Papers
- 14 March 2019
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 79 (6), 1019-1031
- https://doi.org/10.1158/0008-5472.CAN-18-2738
Abstract
Many cellular processes in cancer are attributed to kinase signaling networks. V-akt murine thymoma viral oncogene homolog (AKT) plays a major role in the PI3K/AKT signaling pathways. AKT is activated by PI3K or phosphoinositide-dependent kinases (PDK) as well as growth factors, inflammation, and DNA damage. Signal transduction occurs through downstream effectors such as mTOR, glycogen synthase kinase 3 beta (GSK3 beta), or forkhead box protein O1 (FOXO1). The abnormal overexpression or activation of AKT has been observed in many cancers, including ovarian, lung, and pancreatic cancers, and is associated with increased cancer cell proliferation and survival. Therefore, targeting AKT could provide an important approach for cancer prevention and therapy. In this review, we discuss the rationale for targeting AKT and also provide details regarding synthetic and natural AKT-targeting compounds and their associated studies.Keywords
This publication has 105 references indexed in Scilit:
- Resveratrol Suppresses Constitutive Activation of AKT via Generation of ROS and Induces Apoptosis in Diffuse Large B Cell Lymphoma Cell LinesPLOS ONE, 2011
- 4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in TumorsCancer Cell, 2010
- Akt Phosphorylation at Ser473 Predicts Benefit of Paclitaxel Chemotherapy in Node-Positive Breast CancerJournal of Clinical Oncology, 2010
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human CancerCancer Cell, 2009
- Inhibitor hijacking of Akt activationNature Chemical Biology, 2009
- Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancerEuropean Journal of Cancer, 2009
- Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapyRetrovirology, 2008
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- Exploiting the PI3K/AKT Pathway for Cancer Drug DiscoveryNature Reviews Drug Discovery, 2005
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005